Log In
Print
BCIQ
Print
Print this Print this
 

FT011

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionAnti-fibrotic agent
Molecular Target Not available
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetic nephropathy
Indication DetailsTreat diabetic nephropathy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today